[Federal Register Volume 87, Number 15 (Monday, January 24, 2022)]
[Notices]
[Page 3587]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-00852]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-875]


Importer of Controlled Substances Application: Globyz Pharma, 
LLC; Correction

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application; correction.

-----------------------------------------------------------------------

SUMMARY: The Drug Enforcement Administration (DEA) published a document 
in the Federal Register on August 12, 2021, concerning a notice of 
application. The document indicated the approved drug code (1205--
Lisdexamfetamine) as a schedule I. The correct drug schedule should 
read schedule II.

SUPPLEMENTARY INFORMATION:

Correction

    In the Federal Register of August 12, 2021, in FR Doc. 2021-17181 
(86 FR 44405), on page 44406, in the first column, in the controlled 
substance table, correct the drug schedule to schedule II.

Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2022-00852 Filed 1-21-22; 8:45 am]
BILLING CODE P